These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 18479295)

  • 1. Conjugation of methotrexate to immunoglobulins kills macrophages by Fc receptor mediated uptake?
    Wang X; Yao C; Jiang Z
    Int J Lab Hematol; 2008 Jun; 30(3):185-90. PubMed ID: 18479295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of action of intravenous immunoglobulins.
    Baerenwaldt A; Biburger M; Nimmerjahn F
    Expert Rev Clin Immunol; 2010 May; 6(3):425-34. PubMed ID: 20441428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylation-independent mechanism involved in the amelioration of murine immune thrombocytopenia using intravenous gammaglobulin.
    Leontyev D; Katsman Y; Ma XZ; Miescher S; Käsermann F; Branch DR
    Transfusion; 2012 Aug; 52(8):1799-805. PubMed ID: 22257295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FcgammaRIII-dependent inhibition of interferon-gamma responses mediates suppressive effects of intravenous immune globulin.
    Park-Min KH; Serbina NV; Yang W; Ma X; Krystal G; Neel BG; Nutt SL; Hu X; Ivashkiv LB
    Immunity; 2007 Jan; 26(1):67-78. PubMed ID: 17239631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of efficacy of high-dose intravenous immunoglobulin treatment of severe thrombocytopenia in patients with secondary dengue virus infection.
    Dimaano EM; Saito M; Honda S; Miranda EA; Alonzo MT; Valerio MD; Mapua CA; Inoue S; Kumaori A; Matias R; Natividad FF; Oishi K
    Am J Trop Med Hyg; 2007 Dec; 77(6):1135-8. PubMed ID: 18165536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of anti-inflammatory activity of intravenous immunoglobulin via inhibitory Fcgamma receptors.
    Maródi L
    Pediatr Res; 2001 Nov; 50(5):551. PubMed ID: 11641444
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous immunoglobulin (IVIG)-mediated neutralisation of C5a: a direct mechanism of IVIG in the maintenance of a high Fc gammaRIIB to Fc gammaRIII expression ratio on macrophages.
    Konrad S; Baumann U; Schmidt RE; Gessner JE
    Br J Haematol; 2006 Aug; 134(3):345-7. PubMed ID: 16848778
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preparation and cytotoxicity of McAb-HSA-MTX conjugates].
    Yin Z
    Zhonghua Yi Xue Za Zhi; 1990 Oct; 70(10):556-9, 40. PubMed ID: 2176564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IVIg-mediated amelioration of ITP in mice is dependent on sialic acid and SIGNR1.
    Schwab I; Biburger M; Krönke G; Schett G; Nimmerjahn F
    Eur J Immunol; 2012 Apr; 42(4):826-30. PubMed ID: 22278120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura.
    Jin F; Balthasar JP
    Hum Immunol; 2005 Apr; 66(4):403-10. PubMed ID: 15866704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanisms of action of intravenous immunoglobulin and polyclonal anti-d immunoglobulin in the amelioration of immune thrombocytopenic purpura: what do we really know?
    Crow AR; Lazarus AH
    Transfus Med Rev; 2008 Apr; 22(2):103-16. PubMed ID: 18353251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin ameliorates ITP via activating Fc gamma receptors on dendritic cells.
    Siragam V; Crow AR; Brinc D; Song S; Freedman J; Lazarus AH
    Nat Med; 2006 Jun; 12(6):688-92. PubMed ID: 16715090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo.
    Schwab I; Seeling M; Biburger M; Aschermann S; Nitschke L; Nimmerjahn F
    Eur J Immunol; 2012 Dec; 42(12):3302-9. PubMed ID: 22945870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the mechanism of action of an antibody-targetted drug-carrier conjugate.
    Garnett MC; Embleton MJ; Jacobs E; Baldwin RW
    Anticancer Drug Des; 1985 Oct; 1(1):3-12. PubMed ID: 3879960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity.
    Washburn N; Schwab I; Ortiz D; Bhatnagar N; Lansing JC; Medeiros A; Tyler S; Mekala D; Cochran E; Sarvaiya H; Garofalo K; Meccariello R; Meador JW; Rutitzky L; Schultes BC; Ling L; Avery W; Nimmerjahn F; Manning AM; Kaundinya GV; Bosques CJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(11):E1297-306. PubMed ID: 25733881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulins induce CD32-mediated platelet aggregation in vitro.
    Pollreisz A; Assinger A; Hacker S; Hoetzenecker K; Schmid W; Lang G; Wolfsberger M; Steinlechner B; Bielek E; Lalla E; Klepetko W; Volf I; Ankersmit HJ
    Br J Dermatol; 2008 Sep; 159(3):578-84. PubMed ID: 18565176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of IVIg: physiology of Fc receptors.
    Reilly MP; McKenzie SE
    Vox Sang; 2002 Aug; 83 Suppl 1():57-63. PubMed ID: 12617105
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous immunoglobulin promotes antitumor responses by modulating macrophage polarization.
    Domínguez-Soto A; de las Casas-Engel M; Bragado R; Medina-Echeverz J; Aragoneses-Fenoll L; Martín-Gayo E; van Rooijen N; Berraondo P; Toribio ML; Moro MA; Cuartero I; Castrillo A; Sancho D; Sánchez-Torres C; Bruhns P; Sánchez-Ramón S; Corbí AL
    J Immunol; 2014 Nov; 193(10):5181-9. PubMed ID: 25326025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors.
    Kaneko Y; Nimmerjahn F; Madaio MP; Ravetch JV
    J Exp Med; 2006 Mar; 203(3):789-97. PubMed ID: 16520389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.